102 related articles for article (PubMed ID: 4679652)
1. Clinical observations on the use of primozide in the treatment of chronic schizophrenics.
Frangos E
Acta Psychiatr Belg; 1972 Nov; 72(6):698-707. PubMed ID: 4679652
[No Abstract] [Full Text] [Related]
2. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
Gross HS
Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
[No Abstract] [Full Text] [Related]
3. Pimozide as an adjuvant to maintenance therapy in chronic schizophrenia.
Nakra BR; Wickramasinghe NA
Pharmatherapeutica; 1980; 2(5):337-40. PubMed ID: 6107933
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial of pimozide.
Anumonye A; Onibuwe-Johnson T; Marinho AA
West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):17-24. PubMed ID: 799401
[TBL] [Abstract][Full Text] [Related]
5. Pimozide and the social behavior of schizophrenics.
Lapierre YD; Lavallee J
Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):181-88. PubMed ID: 809233
[No Abstract] [Full Text] [Related]
6. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
Kudo Y
Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
[No Abstract] [Full Text] [Related]
7. [Clinical and statistical evaluation of neuroleptic pimozide].
Glatzel J
Int Pharmacopsychiatry; 1971; 6(1):60-6. PubMed ID: 5163169
[No Abstract] [Full Text] [Related]
8. Clinical experience with Pimozid in schizophrenia.
Tabarka K; Mrna B; Nàdvornìk I; Komenda S
Act Nerv Super (Praha); 1973 May; 15(2):95-6. PubMed ID: 4752684
[No Abstract] [Full Text] [Related]
9. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
Wilson LG; Roberts RW; Gerber CJ; Johnson MH
J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
[TBL] [Abstract][Full Text] [Related]
10. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II.
Vergara L; Amin MM; Ban TA
Psychopharmacol Bull; 1977 Jul; 13(3):17-9. PubMed ID: 329324
[No Abstract] [Full Text] [Related]
11. A new dosage schedule for pimozide in the acute stabilisation and maintenance treatment of psychosis.
Noordhuizen GJ
Acta Psychiatr Belg; 1980; 80(3):329-40. PubMed ID: 7211424
[TBL] [Abstract][Full Text] [Related]
12. Pimozide in the treatment of some "social maladjustments" in "personality disorders".
Collard J
Acta Psychiatr Belg; 1979; 79(6):686-703. PubMed ID: 554447
[TBL] [Abstract][Full Text] [Related]
13. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl.
Abuzzahab FS; Zimmermann RL
Adv Biochem Psychopharmacol; 1980; 24():547-50. PubMed ID: 7405675
[No Abstract] [Full Text] [Related]
14. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
Tanghe A; Vereecken JL
Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
[No Abstract] [Full Text] [Related]
15. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
Denijs EL; Vereecken JL
Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
[No Abstract] [Full Text] [Related]
16. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
17. Results obtained with Orap in the therapy of neuropsychiatric outpatients.
Perényi G; Várkonyi B+VARKONYI B
Ther Hung; 1974; 22(2):65-8. PubMed ID: 4608508
[No Abstract] [Full Text] [Related]
18. Two pilot studies of AHR-1680 in chronic schizophrenic patients.
Sugerman AA; Herrmann J; O'Hara M; Simpson GM; Angus JW; Deutsch L
J Clin Pharmacol J New Drugs; 1969; 9(3):183-6. PubMed ID: 4892454
[No Abstract] [Full Text] [Related]
19. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach.
Baro F; Van Lommel R; Dom R; De Mesmaecker L
Acta Psychiatr Belg; 1972 Mar; 72(2):199-214. PubMed ID: 5056015
[No Abstract] [Full Text] [Related]
20. [Evaluation of the hypnotic properties of promethazine in chronic schizophrenics].
Massac CH; Pinard G; Côte JY; Tétreault L
Int Z Klin Pharmakol Ther Toxikol; 1971 Feb; 4(2):251-9. PubMed ID: 5550422
[No Abstract] [Full Text] [Related]
[Next] [New Search]
